Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Atherogenic low-density lipoproteins (LDLs) are cleared by hepatic LDL receptors (LDLRs).
• Inherited hypercholesterolemia includes autosomal dominant familial hypercholesterolemia (FH) and autosomal recessive hypercholesterolemia (ARH), with ARH etiology previously unknown.
• LDLR activity is essential for cholesterol homeostasis.

Purpose of the Study:

• To identify the genetic basis and molecular mechanism of autosomal recessive hypercholesterolemia (ARH).
• To elucidate the role of the newly identified ARH gene in low-density lipoprotein receptor (LDLR) function.

Main Methods:

• Genetic linkage analysis to map the ARH locus to chromosome 1p35.
• Mutation screening in candidate genes within the mapped interval.
• Analysis of the identified ARH protein's structure and function, including its interaction with LDLR.

Main Results:

• The ARH locus was mapped to a 1-centimorgan region on chromosome 1p35.
• Six mutations were identified in a gene encoding a putative adaptor protein, designated ARH.
• The ARH protein contains a phosphotyrosine-binding (PTB) domain and interacts with NPXY motifs on receptors like LDLR.
• ARH demonstrated a liver-specific requirement for LDLR function.

Conclusions:

• Mutations in the ARH gene cause autosomal recessive hypercholesterolemia.
• The ARH protein functions as a critical adaptor in the liver for low-density lipoprotein receptor-mediated clearance.
• This discovery clarifies the etiology of ARH and highlights a tissue-specific role for ARH in lipoprotein metabolism.